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Autophagy is an important cell-biological process responsible for the disposal of long-lived proteins, protein
aggregates, defective organelles and intracellular pathogens. It is activated in response to cellular stress and
plays a role in development, cell differentiation, and ageing. Moreover, it has been shown to be involved in
different pathologies, including cancer and neurodegenerative diseases. It is a long standing issue whether and
how the Ca2+ ion is involved in its regulation. The role of the inositol 1,4,5-trisphosphate receptor, the main
intracellular Ca2+-release channel, in apoptosis is well recognized, but its role in autophagy only recently
emerged and is therefore much less well understood. Positive as well as negative effects on autophagy have
been reported for both the inositol 1,4,5-trisphosphate receptor and Ca2+. This review will critically present the
evidence for a role of the inositol 1,4,5-trisphosphate receptor/Ca2+-release channel in autophagy and will
demonstrate that depending on the cellular conditions it can either suppress or promote autophagy.
Suppression occurs through Ca2+ signals directed to the mitochondria, fueling ATP production and decreasing
AMP-activated kinase activity. In contrast, Ca2+-induced autophagy can be mediated by several pathways
including calmodulin-dependent kinase kinase β, calmodulin-dependent kinase I, protein kinase C θ, and/or
extracellular signal-regulated kinase.
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Mammalian target of rapamycin, Calmodulin-dependent kinase kinase βReview
What is autophagy?
Autophagy is the name for a group of lysosomal degrad-
ation processes conserved throughout evolution [1,2]. It
is responsible for the disposal of cellular material that
cannot be degraded by the ubiquitin-proteasome system,
like long-lived proteins, other macromolecules and even
entire organelles. Depending on the delivery mechanism
of this material to the lysosomes, autophagy is divided
into three main types: microautophagy, chaperone-
mediated autophagy and macroautophagy [2,3].
The latter is the best-studied form of autophagy and
involves the formation of a typical double-membrane
cistern, named phagophore, which surrounds and ultim-
ately engulfs the cytoplasmic material to be degraded.
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reproduction in any medium, provided the orfuse with late endosomes or lysosomes, leading to the
breakdown of its content [1,4]. Because macroautophagy
is the main focus of this review, it will further be re-
ferred to as autophagy.
Appropriate autophagy levels are not only needed for
cellular homeostasis (removing of aggregated proteins
and damaged organelles) [5,6] but also for development,
cell differentiation, ageing and tumor suppression [1,6,7].
Depending on the type of stress faced by cells, autop-
hagy can either provide the cell with building blocks and
energy (e.g. during starvation) or help the cell to cope
with potentially damaging elements (e.g. aggregated pro-
teins, viral infection and other intracellular pathogens)
[1,4,6,8,9]. Thus, autophagy ensures cell survival, but if
the stress persists for a longer time, it can lead to cell
death, also termed programmed cell death type 2 [10].
Cell death is however not the normal outcome of autop-
hagy, and the concept has been proposed that cell death
may occur along with autophagy rather than executed by
autophagy [11,12].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Relation between IP3R and autophagy. IP3-induced Ca
2+
release towards the mitochondria promotes ATP production,
inhibition of AMPK and thus stimulation of mTOR activity. mTOR can
stimulate the IP3Rs by direct phosphorylation. Inhibition of mTOR
leads to the formation of the ULK1-Atg13-FIP200 complex and
autophagy. In addition, the IP3R might act as scaffold for Bcl-2 and
Beclin 1, thereby promoting the inhibition of Beclin 1 by Bcl-2. Beclin
1 promotes the formation of the PtdIns3K Complex III. Both
complexes are necessary for the formation of the phagophore and
subsequent autophagy. Ca2+ (and calmodulin) can activate multiple
systems in the cell including CaMKKβ, ERK, CaMKI, PKCθ, DAPK,
which phosphorylates Beclin 1, thereby mediating its dissociation
from Bcl-2, and putatively also Vps34, a component of the PtdIns3K
Complex III. The blue box indicates the mitochondrial (Mit.)
compartment. Arrows indicate the flow of the signals; a green arrow
indicates stimulation; a red arrow indicates inhibition; a double
arrow indicates an interaction; a broken arrow indicates a
mechanism that remains to be further defined. For more detailed
explanation, see text.
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cated in several pathologies, including cancer and neuro-
degenerative disorders [1,6,8].
In order to avoid uncontrolled or excessive levels of
autophagy, the process is tightly regulated. More than 30
autophagy genes (atg) have hereby been identified as essen-
tial regulators [1,13]. The mammalian target of rapamycin
(mTOR) is an important upstream negative regulator of
the canonical autophagy pathway. In normal conditions,
mTOR hyperphosphorylates Atg13, thereby inhibiting its
activity. In conditions where mTOR is inhibited, e.g. subse-
quently to activation of the upstream AMP-activated kin-
ase (AMPK), the resulting active Atg13 forms a complex
with Atg1/Unc-51-like kinase 1 (ULK1) and FIP200, the
focal adhesion kinase family interacting protein of 200 kDa
[14]. In addition, mTOR also directly phosphorylates
ULK1 at S757, thereby preventing the interaction between
AMPK and ULK1. During starvation, AMPK directly acti-
vates ULK1 by phosphorylation on S317 and S777 [15,16].
The ULK1 complex together with the class III phosphati-
dylinositol 3-kinase complex (PtdIns3K Complex III),
which mainly consists of PtdIns3K (Vps34), Vps15, Atg6/
Beclin 1 and Atg14/Barkor [17], are necessary for phago-
phore formation (Figure 1).
Beclin 1 plays a central and critical role in these initial
steps as a platform protein, recruiting other regulatory
proteins to the PtdIns3K Complex III [18]. It was origin-
ally identified as a 60 kDa Bcl-2-interacting protein [19].
Structurally, it consists of an N-terminal domain con-
taining a BH3 domain, a central coiled-coil domain, and
a C-terminal evolutionarily conserved domain. Although
other functions are possible [20], its best-characterized
function is its role in autophagy; moreover, in contrast
to the other BH3-only proteins, it does not promote
apoptosis [13,21,22]. In normal conditions, Beclin 1 is
neutralized by binding through its BH3 domain to the
hydrophobic cleft of the anti-apoptotic Bcl-2-protein
family members Bcl-2, Bcl-Xl, Mcl-1 and Bcl-w. Their
interaction can be dynamically regulated by various
mechanisms, allowing the release of Beclin 1 and subse-
quent activation of the PtdIns3K Complex III during
autophagy-inducing conditions [23]. A first mechanism
involves phosphorylation of either Bcl-2 or Beclin 1. Bcl-
2 can be phosphorylated by c-Jun NH2-terminal kinase-
1 (JNK1) [24], and Beclin 1 by death-associated protein
kinase (DAPK) [25]. Either phosphorylation opposes the
interaction between the two proteins. Also a number of
regulatory proteins can modulate the interaction of
Beclin 1 with Bcl-2 [26]. For instance, under hypoxic
conditions, BNIP3 will bind Bcl-2 and Bcl-Xl through its
BH3 domain, thereby dissociating Beclin 1 from them
and triggering autophagy [27]. After starvation and re-
active oxygen species production, HMGB1, the High
Mobility Group Box 1 protein, translocates to thecytosol, where it can disrupt the Beclin 1/Bcl-2 complex
and thus induce autophagy [28]. Another protein that
can play a role in this process is Nutrient-deprivation
Autophagy Factor-1 (NAF-1). NAF-1 binds both Bcl-2
and the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R),
stabilizing the Beclin 1/Bcl-2 interaction and inhibiting
the induction of autophagy [29]. In addition, other
Beclin 1-associated proteins also can enhance (Ambra-1,
UVRAG or Bif-1) or inhibit (Rubicon) Beclin 1’s
autophagy-stimulating functions [17]. Furthermore, re-
cent work identified the importance of the intracellular
localization and membrane recruitment of Beclin 1 for
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Beclin 1 and Bcl-2 are also found at the mitochondria,
inhibition of Beclin 1’s function in autophagy mainly
depends on Bcl-2 that is located at the endoplasmic
reticulum (ER) [26]. In addition, membrane anchoring of
Beclin 1 seems a critical factor in its ability to induce
autophagy. Beclin 1 was recently shown to bind to lipid
membranes containing either cardiolipin or other lipids
favoring a negative curvature, which may be related to
the formation of omegasomes, the early precursors of
autophagosomes [30]. Three aromatic amino acids
(F359, F360 and W361) responsible for this interaction
have been identified and seemed critical for Beclin 1’s
role in autophagy. Indeed, Beclin 1 mutants lacking
these three aromatic residues fail to bind lipid mem-
branes and are impaired in their ability to rescue autop-
hagy in Beclin 1-deficient cells.
Once the phagophore is formed, its further elongation
depends on the formation of the Atg5-Atg12-Atg16L1
complex [31] and the lipidation with phosphatidylethano-
lamine of microtubule-associated protein 1 light chain 3
(Atg8/LC3) to LC3-II. The lipid tail enables LC3-II inser-
tion into the membrane [31]. The resulting autophago-
somes are subsequently transported along microtubules
via a dynein-dependent mechanism. Final fusion with
endosomes and lysosomes is regulated by ESCRTIII,
SNAREs, Rab7 and class C Vps proteins [32].
Interestingly, the processes of apoptotic cell death and
of pro-survival autophagy are interrelated in a complex
way. They can have antagonistic, additive or even syner-
gistic effects, depending on cell type and conditions [6].
This interplay is also evident from the molecular interac-
tions occurring between apoptosis- and autophagy-related
proteins, including the Beclin 1/Bcl-2 interaction. Also the
pro-apoptotic tumor suppressor p53 has regulatory effects
on autophagy, while p62 is not only involved in the deliv-
ery of cargo to the autophagosomes, but also in caspase 8
activation [6]. Many Atg proteins also serve as caspase
substrates [33], whereby the cleaved C-terminal fragment
of Beclin 1 even gains pro-apoptotic functions [34]. A
similar switch from pro-autophagic to pro-apoptotic func-
tions were found upon calpain-mediated cleavage of Atg5
[35], indicating many levels of interaction between those
two pathways. In addition, Ca2+ is a well-known regulator
of many intracellular processes, including apoptosis
[36,37]. Especially the IP3R, a Ca
2+ channel mainly located
in the ER, plays hereby a crucial role [38,39]. More re-
cently, it appeared that the IP3R may also play an import-
ant role in the control of autophagy, though the available
data on the role of Ca2+ and the IP3R in autophagy are at
least partially contradictory [40,41].
In this review, we will therefore critically review the
available evidence on the role of the ER Ca2+ store and
in particular of the IP3R in the regulation of autophagy.While the role of the IP3R in controlling apoptosis is
already well-established, its function in regulating autop-
hagy only quite recently emerged. The available data
however not only support a role for the IP3R and for
IP3-induced Ca
2+ release in the control of autophagy,
but indicate that this role can depend on the exact con-
ditions and so either has a preventing or an enhancing
role with respect to autophagy.Role of the IP3R in autophagy
Importance of intracellular Ca2+ in autophagy
The role of Ca2+ in the regulation of autophagy has been
investigated since 1993 [42], and the first study already
indicated a complex role for Ca2+ as both an increase
and a decrease in the cytosolic [Ca2+] suppressed autop-
hagy. This complexity was not directly resolved as fur-
ther reports suggested that intracellular Ca2+ signaling
and Ca2+-handling proteins inhibited autophagy, while
other reports indicated a stimulatory role for Ca2+
(reviewed in [40]). Although Ca2+ release from the ER
has hereby a major role, it is important to note that also
other intracellular compartments may contribute to the
control of autophagic flux by Ca2+, including the lyso-
somes. For instance, in rat astrocytes, nicotinic acid ad-
enine dinucleotide phosphate (NAADP) has been shown
to trigger Ca2+ release from these acidic compartments
via the two-pore channels and so to induce autophagy
[43]. Interestingly, the leucine-rich repeat kinase-2 can
induce autophagy by, directly or indirectly, activating
this pathway, leading to an increase in cytosolic [Ca2+],
possibly also activating Ca2+-induced Ca2+ release from
the ER, and finally activating calmodulin-dependent kin-
ase kinase β (CaMKKβ) and AMPK [44].The IP3R
In any case, there is no doubt that intracellular Ca2+ sig-
nals affect autophagy with hereby a prominent role for
the ER as the main intracellular Ca2+ store and the IP3R
as the most ubiquitously expressed intracellular Ca2+-re-
lease channel. Three genes encode an IP3R, leading to the
expression of three IP3R isoforms (IP3R1, IP3R2, IP3R3).
All IP3R isoforms are activated upon cell stimulation,
phospholipase C activation and subsequent IP3 produc-
tion. IP3 diffuses into the cytoplasm and binds and acti-
vates the IP3R, leading to IP3-induced Ca
2+ release. The
IP3R isoforms vary in a number of properties, including
their affinity for IP3 and their regulation mechanisms.
Main regulatory factors are the cytosolic and the luminal
[Ca2+], ATP, their phosphorylation status and their inter-
action with regulatory proteins [45-47]. The subsequent
complex spatio-temporal Ca2+ signals occurring in the
cell regulate many intracellular processes, including cell
death [36-39,48].
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A first study implicating the role of the IP3R in autop-
hagy was based on the use of Li+ [49]. Li+ induced autop-
hagy by inhibiting inositol monophosphatase, and
subsequently decreasing IP3 levels. Autophagy was
induced in an mTOR-independent manner, as no de-
crease in phosphorylation of mTOR substrates was
observed, and it was proposed that the IP3R acted as an
inhibitor of autophagy. This finding was confirmed in an-
other study, demonstrating that in HeLa cells chemical
inhibition of IP3Rs with xestospongin B (XeB), a potent
and selective IP3R antagonist [50] or suppression of IP3R
expression using siRNA also induced autophagy [51].
To further investigate the role of the IP3R, several
groups investigated the properties of the IP3R triple
knock out chicken DT40 B lymphocytes (TKO cells) ori-
ginally developed by T. Kurosaki [52]. These cells dis-
played higher levels of autophagic markers than their
wild-type counterparts in two studies [53,54], but not in
a third one [55]. The variation between those results
may however be due to the exact experimental condi-
tions, as these cells appear extremely sensitive to nutri-
ent supply [40]. Anyway, in both studies demonstrating
higher basal autophagy levels in the TKO cells, heterol-
ogous expression of either IP3R1 or IP3R3, but not of
the type 2 ryanodine receptor, another ER Ca2+-release
channel, suppressed autophagic levels [53,54].
It was proposed that the control of autophagy by the
IP3R depended on the binding of Beclin 1 to the IP3R
[55]. In this scaffolding model, the IP3R facilitates the
binding of Beclin 1 to Bcl-2 by recruiting both proteins.
This model is attractive, because Beclin 1 and Bcl-2 have
been proposed to target distinct IP3R regions with Beclin
1 binding to the IP3-binding domain [55] and Bcl-2 pre-
dominantly binding in the middle of the modulatory and
transducing domain [56,57]. Moreover, it was proposed
that XeB would dissociate Beclin 1 from the IP3R/Bcl-2
complex and so induce autophagy [55]. According to this
model, the IP3R Ca
2+-channel function would not be
involved. Correlating with this, siRNA-mediated knock
down of Beclin 1 did neither affect histamine-induced
Ca2+ release nor the steady-state ER Ca2+ content [55].
Control of autophagy by the IP3R but independently of
IP3-induced Ca
2+ release was however not confirmed in
other studies. TKO cells expressing channel-dead IP3R
mutants (IP3R1 D2550A, IP3R3 D2550A or T2591A)
had, in contrast to those expressing wild-type IP3R1 or
IP3R3, similar levels of autophagic markers as control
TKO cells [53,54]. This strongly suggests that Ca2+ re-
lease through the IP3R is critical for the inhibition of
autophagy by the IP3R, and it was proposed that this
was related to a regulation of mTOR activity [53].
The group of K. Foskett performed a very detailed
study to clarify the inhibitory effect of the IP3R onautophagy induction [54]. It is well established that a
fraction of the IP3Rs are present in ER domains forming
close associations with the mitochondria [58]. These
domains are structurally stabilized by various proteins,
and allow efficient transfer of Ca2+ ions from the ER to
the mitochondria [48,59-61]. The study by Cárdenas
et al. [54] showed in TKO cells increased glucose and
decreased O2 consumption, pyruvate dehydrogenase in-
hibition and AMPK activation. These observations sug-
gest a mechanism in which constitutive Ca2+ release
through IP3Rs fuels into the mitochondria, thereby aug-
menting mitochondrial bio-energetics and ATP produc-
tion [54]. Also in neuroblastoma cells these essential Ca2+
signals could be abolished via siRNA-mediated knock
down or XeB-mediated inhibition of IP3Rs, leading to a
decreased ATP production, an increased AMP/ATP ratio
and subsequent AMPK activation and autophagy stimula-
tion. As mTOR activation appeared unaffected, a non-
canonical AMPK-dependent stimulation of autophagy was
proposed [54]. A possible pathway is e.g. via direct phos-
phorylation of ULK1 by AMPK [15].
In follow-up on these results, recent data indicate that
Bax inhibitor-1 (BI-1) overexpression promotes autop-
hagy by decreasing ER Ca2+ store content, decreasing
thereby IP3R-mediated Ca
2+ transfer to the mitochon-
dria, O2 consumption, and ATP production, and thus
leading to AMPK stimulation and autophagy induction
[62]. Moreover, BI-1 overexpression in TKO cells was
without effect, further demonstrating that BI-1 induced
autophagy via a pathway requiring the IP3R.
Although it is not yet clearly established by which
pathway AMPK activation leads to autophagy induction
in response to IP3R inhibition, it is clear that conditions
suppressing IP3R activity cause autophagy induction via
a mitochondrial pathway [41]. Under a normal situation
however, basal autophagy levels are kept minimal
through a Ca2+- and IP3R-dependent mechanism, al-
though an additional scaffold function for the IP3R can-
not be excluded. Moreover, the relation between the
IP3R and mTOR activity may form a feedback loop, as it
was shown that the various IP3R isoforms can be phos-
phorylated and stimulated by mTOR [63-65] (Figure 1).
The IP3R can promote autophagy
In contrast to the previous, other results indicated that
intracellular Ca2+ signaling, and hence potentially the
IP3R, can activate autophagy. Several of those studies
[66-69] were based on the use of thapsigargin, a potent
sarco/endoplasmic reticulum Ca2+- ATPase inhibitor.
Treatment of cells with thapsigargin results in an in-
crease in their cytosolic [Ca2+] and increased autophagy.
Similar results were found for other treatments that
increased [Ca2+] (reviewed in [40]). As the induction of
autophagy by Ca2+-mobilizing agentia was counteracted
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proteins involved in the unfolded protein response
(IRE1α, eIF2α, ATF6) [67], it can be assumed that the in-
duction of the autophagic flux was not consecutively to
ER stress, an event triggered by the depletion of the ER
Ca2+ stores [40]. Although this does not exclude a priori
a role for Ca2+ originating from other compartments,
the existing data support an important role for the ER
Ca2+ stores in autophagy induction and in a number of
studies a direct role for the IP3R herein was even
presented.
In a first study, it was assumed that the Cd2+-induced
autophagy was linked to Ca2+ mobilization via IP3Rs
[70]. The involvement of IP3Rs was deduced from indir-
ect evidence based on the use of the IP3R inhibitor 2-
aminoethoxydiphenyl borate (2-APB) and the siRNA-
mediated knock down of Ca2+/calmodulin-dependent
phosphatase calcineurin putatively acting on the IP3R.
However, 2-ABP is not specific for the IP3R [71,72], and
it has not yet been clarified in which circumstances cal-
cineurin exactly regulates IP3R activity [46,73].
A second study indicating a role for the IP3R in autop-
hagy was performed in the slime mold Dictyostelium
discoideum [68]. Because this organism lacks the apop-
totic machinery, autophagy can be studied in the ab-
sence of any interference by apoptosis [74]. Importantly,
in this organism, the differentiation factor DIF-1 led
from starvation-induced autophagy to autophagic cell
death, which did not occur when the unique IP3R gene
was inactivated by random insertional mutagenesis or
when IP3-induced Ca
2+ signaling was blocked by
BAPTA-AM [68].
Finally, in mammalian cell lines, we recently determined
that the induction of autophagy triggered by nutrient star-
vation occurred concomitantly with a remodeling of the
proteins involved in ER Ca2+ homeostasis and dynamics,
thereby sensitizing multiple Ca2+-handling mechanisms.
During the initial phase of the autophagy response, the
levels of the Ca2+-binding chaperones calreticulin and
GRP78/BiP increased and ER Ca2+ leak decreased, result-
ing in an elevation of the steady state ER Ca2+ levels, while
the sensitivity of the IP3R towards IP3 increased [75]. This
sensitization of the Ca2+-flux properties of the IP3R was
not only indirectly due to the increased ER Ca2+-store
content, but also involved direct effects through increased
Beclin 1 binding to the IP3R. Functional experiments sug-
gested that predominantly the N-terminal part of Beclin
1, containing the BH3 domain, was involved in this
stimulation. Moreover, Beclin 1 appears to interact with
the N-terminal part of the IP3R, especially in its suppres-
sor domain (a.a. 1–225) [75]. This domain regulates at
the one hand the affinity of the IP3R for IP3 [76] and
at the other hand interacts with and regulates its C-
terminal Ca2+-channel domain [77]. Importantly thissensitization of the IP3R is essential for the proper in-
duction of autophagy upon nutrient starvation, as cells
loaded with BAPTA-AM displayed an impaired autop-
hagic flux [75]. This is in agreement with results from
other groups demonstrating that autophagy induction
in response to various autophagic triggers, including
nutrient deprivation, was also inhibited by BAPTA-AM
[78-81]. Results obtained with the IP3R inhibitor XeB
were more complex, because XeB induced autophagic
flux in normal cells, but suppressed autophagic flux in
starved cells [75]. This points towards a dual role for
IP3R function in autophagy depending on the cellular
condition. In normal cells, IP3Rs suppress autophagic
flux by fueling Ca2+ into the mitochondria to sustain
ATP production, thereby preventing AMPK activity
[41,54]. In nutrient-deprived cells, however, IP3Rs are
required to promote Ca2+-signaling events that are
critical for up-regulating autophagic flux [40,75].
As Bcl-2 can suppress IP3-induced Ca
2+ release
[56,82,83], it may be argued that IP3R sensitization by
Beclin 1 is an indirect effect, due to its effects on Bcl-2,
e.g. by dissociating Bcl-2 from IP3Rs. However, a Beclin
1 mutant unable to bind Bcl-2 [84] remained able to
sensitize IP3-induced Ca
2+ release in vitro, indicating
that these events were not due to a suppression of the
inhibitory effect of Bcl-2. Nevertheless, in a cellular con-
text, Bcl-2 seems to play an important role in tethering
Beclin 1 at the ER membranes in the proximity of the
IP3R channel [75].
Autophagy can be positively or negatively regulated by the
IP3R
Taken together these various results indicate a complex
action of the IP3R in autophagy regulation, whereby de-
pending on the state of the cells IP3-induced Ca
2+ re-
lease can suppress or promote autophagy (Figure 1).
This complex behavior probably also explains in part the
contradictory results obtained in cells treated with thap-
sigargin or BAPTA-AM. Indeed, differing cellular condi-
tions, concentrations of the applied chemicals and
incubation times could underlie the different results
obtained in different studies [40]. Finally, also the
localization of the IP3Rs and the subcellular localization
of the resulting Ca2+ signals (cytosol or mitochondria)
may determine the specific outcome on autophagy. In
addition, it can be expected that regulators of the IP3R
may impinge on the cellular autophagy levels by modu-
lating IP3-induced Ca
2+ release. Main regulators in this
context are obviously Beclin 1 and Bcl-2, though their
exact regulation by associated proteins or phosphoryl-
ation events remains to be explored. Moreover, as these
same proteins control apoptosis [6,48], it is extremely
important to dissect their relative role and activation
mechanisms in both processes.
Parys et al. Cell Communication and Signaling 2012, 10:17 Page 6 of 9
http://www.biosignaling.com/content/10/1/17Downstream targets of Ca2+ in Ca2+-induced autophagy
From the above, it is clear that IP3-induced Ca
2+ release
can induce autophagy. However, the Ca2+-dependent
mechanisms involved and the target(s) of the intracellu-
lar Ca2+ signal remain elusive, although different
mechanisms have already been proposed (Figure 1).
Based on experiments using inhibitors of CaMKKβ
(STO-609) or of AMPK (compound C) as well as
siRNA-mediated knock down of these enzymes, it was
proposed that autophagy induced by thapsigargin or
other Ca2+-mobilizing agents was mediated via
CaMKKβ, thereby activating its downstream target
AMPK [66,79,85]. The latter is a negative regulator of
mTOR while a positive regulator of ULK1, both result-
ing in the induction of autophagy. However, since thap-
sigargin also induced mTOR inhibition and autophagy
in AMPK knock-out cells [69], although to a lesser
extent, an AMPK-independent pathway for autophagy
induction is also likely present. In follow up of this
study, a recent study elegantly demonstrated that
CaMKI was also activated and played a role in autop-
hagy [81]. In particular, it was shown that CaMKI sti-
mulated the formation autophagosomes in a pathway
involving PtdIns3K Complex III but independently of
AMPK (Figure 1). In this respect, it is important to
mention that Vps34, a component of the PtdIns3K
Complex III, was already reported to be activated by
Ca2+ and calmodulin [86], although this finding was
later disputed [87].
In a study using hepatocytes and fibroblasts, thapsigar-
gin induced autophagy through ER stress without inhi-
biting mTOR activity. Phosphorylation of protein kinase
C θ (PKCθ) was hereby critical [67]. Treatment with
BAPTA-AM decreased both PKCθ phosphorylation and
autophagy, demonstrating that Ca2+ is needed for PKCθ
phosphorylation, though the mechanism remains elusive.
Preliminary data indicate that the phospholipase C in-
hibitor U73122 partially inhibited ER stress-induced
autophagy [67], underpinning a role for the IP3R. Inter-
estingly, in amino acid starvation-induced autophagy no
role for PKCθ was found, suggesting that this pathway is
preferentially used during ER stress.
In mesangial cells, Cd2+ treatment triggers Ca2+ re-
lease from the ER, putatively by activation of the IP3R,
and induces both autophagy and apoptosis. Extracellular
signal-regulated kinase (ERK) activation was observed,
and inhibition of ERK selectively suppressed the autop-
hagic response, but not the apoptotic cell death response
[70]. As ERK activity was inhibited by BAPTA-AM, this
study suggests a role for ERK in Ca2+-induced autop-
hagy, although the target of ERK was not elucidated. It
is hereby interesting to note that ERK may be involved
in the phosphorylation of Bcl-2, thereby leading to
Beclin 1 release from Bcl-2 [28,88]. Moreover, previousstudies had also demonstrated that ERK can be involved
in autophagy through regulation of Gα-interacting pro-
tein [89] or of the microtubuli [90].
The induction of autophagy by cytosolic Ca2+ may
therefore depend of one or more of these mechanisms,
but the situation might also be more complex, as several
other proteins regulating autophagy are known to be
influenced by Ca2+. These proteins include DAPK, which
is regulated by calmodulin and which can phosphorylate
Beclin 1, thereby dissociating it from Bcl-2 and inducing
autophagy [25]. Finally, members of the S100 Ca2+-bind-
ing protein family [40] as well as eEF-2 kinase, respon-
sible for the phosphorylation of eukaryotic elongation
factor (eEF)-2 [91] have also be implicated in the regula-
tion of autophagy.
Taken together, these data indicate that an induction
or a regulation of autophagy by Ca2+ is very plausible
and that depending on the cell type or the cell state vari-
ous mechanisms can be involved.
Conclusion
In conclusion, the available data indicate that ER Ca2+-
store content, the IP3R and IP3-induced Ca
2+ release act
on the autophagic process. Under normal conditions, a
basal level of IP3-induced Ca
2+ release from the ER to
the mitochondria is responsible for a certain level of
ATP production, sufficient for keeping AMPK inactive
and therefore precluding induction of autophagy. If Ca2+
transfer to the mitochondria decreases below a certain
threshold, ATP synthesis is not anymore guaranteed,
AMP/ATP ratio increases and AMPK is activated, lead-
ing to autophagy. Under stress conditions however,
Beclin 1 may interact with the IP3R, leading to an
increased IP3-induced Ca
2+ release. At least part of the
released Ca2+ diffuses to the cytosol where it can stimu-
late the induction of autophagy via a not yet completely
understood pathway. This pathway may either involve
CaMKKβ and AMPK, or develop in an AMPK-
independent way. Whatever the mechanism, this dual
regulation of autophagy by the IP3R and Ca
2+ is of para-
mount importance for the determination of cell fate. As
autophagy is important in pathological situations as e.g.
cancer and neurodegenerative diseases [1,6,8], the cor-
rect understanding of autophagy regulation by Ca2+ may
lead to important therapeutical consequences.
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